TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ORGO

Organogenesis Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

1.40$ +4.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Organogenesis Holdings Inc (ORGO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -10 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ORGO
Line item 2001 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-1.4 -10 -0.6 -0.6 -61 -34 5.5 62 25 31 14 -10
0.3 7.7 7.3 5.6 7.0 9.4 8.2 17 11 23 17 27
0.5 0.5 0.9 1.1 0.9 1.7 3.9 6.6 9.0 11 13
0.2 7.2 12 0.5 10 7.2 7.5 -25 15
-2.9 -0.4 1.5 -22 -9.7 -28 -39 -34 -18 -49 -132
1.0 0.5 1.4 2.4 1.9 6.2 18 31 34 24 10 14
-0.8 -0.4 -310 -15 -1.9 -6.2 -23 -31 -34 -24 -10 -14
0.0 58 1.5 0.6 1.8 11
0.0 0.0 312 0.1 -6.8 62 -0.7 -0.6 -0.3 -25 0.0
0.5 9.0 12 21 1.1 38 -16 2.2 -2.8 -5.2 -68 -1.2
1.5 11 311 -0.3 82 79 42 -1.0 -2.2 -5.5 28 -17
-0.7 0.2 0.9 -0.9 19 39 24 30 -11 1.0 32 -42
-11 -1.9 -3.0 -63 -40 -12 31 -9.0 6.6 4.2 -24

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?